Search results for ' OXFORD DR'

J&J seeks permission for trial of 1-shot Covid vaccine in India

J&J seeks permission for trial of 1-shot Covid vaccine in India

Rediff.com20 Apr 2021

The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.

New Covid strains may lead to spike in hospitalisation, fear experts

New Covid strains may lead to spike in hospitalisation, fear experts

Rediff.com27 Oct 2022

An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.

Germany, France, Italy suspend use of AstraZeneca vaccine

Germany, France, Italy suspend use of AstraZeneca vaccine

Rediff.com15 Mar 2021

The British-Swedish pharmaceutical major and the UK's medicines regulator said that the vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe.

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

Rediff.com2 Dec 2020

The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer, they said.

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

COVID-19 vaccine by Oct-Nov: Serum Institute CEO

Rediff.com22 Jul 2020

Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.

AIIMS chief among volunteers for Covaxin's phase-3 trial

AIIMS chief among volunteers for Covaxin's phase-3 trial

Rediff.com26 Nov 2020

The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.

Real Heroes Of Web Revolution

Real Heroes Of Web Revolution

Rediff.com21 Mar 2023

The tech creators, or the ones who made billions, asks Ajit Balakrishnan.

Serum Institute's race to produce COVID-19 vaccine

Serum Institute's race to produce COVID-19 vaccine

Rediff.com23 May 2020

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'

PM to meet COVID-19 vaccine manufacturers on today

PM to meet COVID-19 vaccine manufacturers on today

Rediff.com20 Apr 2021

During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.

Cyber war? Not possible, says a study

Cyber war? Not possible, says a study

Rediff.com18 Jan 2011

Heavy lobbying, lurid language and poor analysis are inhibiting government planning for cyber protection, according to the new report on Systemic Cyber Security published by the Organisation for Economic Cooperation and Development.

Man dies days after participating in Covaxin trial

Man dies days after participating in Covaxin trial

Rediff.com9 Jan 2021

The vaccine maker Bharat Biotech said in a statement that preliminary reviews indicated that the death was unrelated to Covaxin.

Arvind Subramanian stays on as CEA

Arvind Subramanian stays on as CEA

Rediff.com23 Sep 2017

The government has retained Arvind Subramanian as its chief economic advisor, unlike other American professors Dr Raghuram Rajan and Arvind Panagariya, who quit their jobs as RBI governor and NITI deputy chairman respectively.

Eminent economist Isher Judge Ahluwalia passes away

Eminent economist Isher Judge Ahluwalia passes away

Rediff.com26 Sep 2020

Her research was focused on urban development, macro-economic reforms, industrial development, and social sector development issues in India.

India gets 3rd vaccine as DCGI approves Sputnik V

India gets 3rd vaccine as DCGI approves Sputnik V

Rediff.com13 Apr 2021

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.

How Obama, Trump, Biden Greeted Modi...

How Obama, Trump, Biden Greeted Modi...

Rediff.com28 Sep 2021

Did Prime Minister Modi receive a different kind of reception at the Biden White House on Friday than he has has been used to at the American president's home?

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

Rediff.com12 May 2021

Several states and UTs including Delhi, Maharashtra, Karnataka and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply falling short to meet the rising demand.

Two doses of vaccine will be needed 28 days apart: Govt

Two doses of vaccine will be needed 28 days apart: Govt

Rediff.com12 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said vaccine effectiveness will be seen only after 14 days.

India would get COVID-19 vaccine by year-end: Vardhan

India would get COVID-19 vaccine by year-end: Vardhan

Rediff.com24 Aug 2020

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

WHO nod for Covaxin expected any time now

WHO nod for Covaxin expected any time now

Rediff.com26 Oct 2021

A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.

India's COVID vaccine rollout has rescued the world: Top US scientist

India's COVID vaccine rollout has rescued the world: Top US scientist

Rediff.com7 Mar 2021

During the webinar, 'COVID-19: Vaccination and Potential Return to Normalcy - If and When', Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

Made-in-India Covaxin gets WHO's emergency use licence

Made-in-India Covaxin gets WHO's emergency use licence

Rediff.com3 Nov 2021

Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements, said the global health body.

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

Rediff.com21 Apr 2021

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

Meet Adar Poonawala, India's COVID-19 vaccine man

Meet Adar Poonawala, India's COVID-19 vaccine man

Rediff.com6 Aug 2020

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine. Sohini Das profiles its 39-year-old CEO.

India receives 1st consignment of 1.5 lakh Sputnik V vaccine doses from Russia

India receives 1st consignment of 1.5 lakh Sputnik V vaccine doses from Russia

Rediff.com1 May 2021

Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.

How qualified are our PMs?

How qualified are our PMs?

Rediff.com20 May 2004

Dr Manmohan Singh is probably the most highly qualified Indian to serve as PM.

Speedy distribution of vaccine major global challenge: WHO experts

Speedy distribution of vaccine major global challenge: WHO experts

Rediff.com5 Jan 2021

As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, two prominent Indian scientists at World Health Organisation have said.

Covid vaccine to be available for every Indian till 2024: Poonawalla

Covid vaccine to be available for every Indian till 2024: Poonawalla

Rediff.com19 Nov 2020

Poonawalla said the price will be around USD 5-6 per dose with an MRP of around Rs 1,000 for the two necessary doses.

WHO seeks 'additional clarifications' from Bharat Biotech

WHO seeks 'additional clarifications' from Bharat Biotech

Rediff.com27 Oct 2021

The technical advisory group will now meet on November 3 for a final assessment.

10 things to know about COVID-19 vaccines

10 things to know about COVID-19 vaccines

Rediff.com16 Jan 2021

As India holds its breath for the Covid vaccination to be begin, Sudhir Bisht provides a quick checklist of what you must know about the vaccines that will be administered to citizens.

4 more Covid vaccines in pipeline: Health ministry

4 more Covid vaccines in pipeline: Health ministry

Rediff.com12 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

Rediff.com29 Nov 2020

Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, 'manufacture and distribution', failing which legal action would be taken.

Be ready to receive first supply of COVID-19 vaccine: Govt to states

Be ready to receive first supply of COVID-19 vaccine: Govt to states

Rediff.com7 Jan 2021

The further distribution of vaccine to the districts will be done as per the registered beneficiaries, for which a separate communication will be done shortly, the letter stated.

Docs join duty soon after getting jabbed

Docs join duty soon after getting jabbed

Rediff.com16 Jan 2021

Messages of congratulations, doctors posing with a victory sign for the media with their infectious smiles -- visible even under the cover of mask -- and the many 'just got jabbed' selfie by the health workers, it was a rare and happy day at the BLK hospital, which has witnessed many dreary days in the past due to the ongoing pandemic.

COVID Deaths: Why India, WHO Are At Loggerheads

COVID Deaths: Why India, WHO Are At Loggerheads

Rediff.com26 Apr 2022

'If deaths had been properly reported, it would have helped contain the pandemic.'

'Make caste discrimination in schools and colleges a crime'

'Make caste discrimination in schools and colleges a crime'

Rediff.com1 Jun 2023

'The government should immediately enact an Act to make caste discrimination a criminal offence and lay down a procedure similar to that of the Anti-Ragging Act.' 'Ragging has nearly been eliminated because it is treated as a criminal offence.' 'Similar procedure should be used in case of caste discrimination.'

Why Google is celebrating Cornelia Sorabji

Why Google is celebrating Cornelia Sorabji

Rediff.com15 Nov 2017

Lesser known facts about India's first female lawyer.

COVID-19 Vaccine: 'Keep science away from politics'

COVID-19 Vaccine: 'Keep science away from politics'

Rediff.com16 Jul 2020

'No matter how much the political pressure is, I cannot say I will bring the Moon for you tomorrow!'